Results 261 to 270 of about 174,736 (301)

Trained Immunity and Cardiovascular Risk: An Immunological Perspective

Immunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Systemic inflammation is a key driver of atherogenesis and its complications. While anti‐inflammatory therapies targeting pathways such as IL‐1β and IL‐6 have shown promise in established atherosclerotic cardiovascular disease (ASCVD), potential systemic effects raise concerns about immune suppression and infection, underscoring the need for ...
Katherine A. Boden, Jason Chai, Tafadzwa T. J. Kufazvinei, Robin P. Choudhury   +3 more
wiley   +1 more source

Nervous Diseases, Arising from Liver and Stomach Complaints, Low Spirits, Indigestion, Gout, and Disorders Produced by Tropical Climates; with Cases.

openalex   +1 more source

Association of Weight‐Adjusted Waist Index With Hypertension Plus Hyperuricemia Among Middle‐Aged and Older Adults in China: A Cross‐Sectional Analysis

The Journal of Clinical Hypertension, Volume 28, Issue 1, January 2026.
ABSTRACT The weight‐adjusted waist index (WWI) is a novel indicator that could estimate body fat and muscle mass. This study aimed to investigate the relationship between WWI and hypertension plus hyperuricemia (HTN‐HUA). The data were drawn from the China Health and Retirement Longitudinal Study.
Shijie Yang, Zhanyang Zhou, Long Feng, Yuqing Zhang, Ying Liang   +4 more
wiley   +1 more source

Association between frailty and gout in middle-aged and older adults: A nationwide cross-sectional and Mendelian randomization study. [PDF]

Medicine (Baltimore)
Sun Y, Liu W, Li D, Cen Z, Shen Y, Zhao T, Lu Z, Liu X, Xie X.   +8 more
europepmc   +1 more source

Global burden of gout among young people from 1990 to 2021, with projections for 2050: A systematic analysis based on the Global Burden of Disease Study 2021. [PDF]

PLoS One
Tian P, Zhao H, Wang B, Chen Y, Jia Z, Wang C, Wang G.   +6 more
europepmc   +1 more source

HUBUNGAN KEPATUHAN MINUM OBAT DENGAN KUALITAS HIDUP PASIEN GOUT ARTHRITIS DI WILAYAH PUSKESMAS LAMONGAN [PDF]

RISZKA PERTIWI, -
openalex  

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 Diabetes

Journal of the American Geriatrics Society, Volume 74, Issue 1, Page 96-106, January 2026.
Effect of glucagon‐like peptide‐1 receptor agonist therapy on cardiorenal outcomes in patients aged ≥ 80 years with Type 2 diabetes. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated potential in improving glycemic control and reducing adverse outcomes in patients with Type 2 diabetes mellitus (T2DM); however ...
Jui‐Cheng Chen, Yu‐Wei Fang, Ya‐Fang Liu, Mon‐Ting Chen, Ming‐Hsien Tsai   +4 more
wiley   +1 more source

Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate-Lowering Therapy: A Phase 2, Randomized, Open-Label, Multicenter, Active-Controlled Trial. [PDF]

ACR Open Rheumatol
Yu Y, Xue Y, Hu J, Zhang N, Li R, Guo H, Qian L, Gou W, Yang J, Mao L, Yu J, Liu S, Xu Q, Luo T, Zou H.   +14 more
europepmc   +1 more source

Therapeutic Effects of Gallic Acid and Alpha‐Tocopherol on Adenine‐Induced Chronic Kidney Disease in Male Wistar Rats

Biochemistry Research International, Volume 2026, Issue 1, 2026.
Chronic kidney disease (CKD) is a major health issue associated with oxidative stress and inflammation that leads to progressive renal damage. Natural antioxidants, gallic acid (GA) and alpha‐tocopherol (AT), have gained attention for their strong free radical‐scavenging, inflammation‐reducing, and tissue‐repairing properties, and their individual or ...
Momita Rani Baro, Manas Das, Kishore Sarma, Leena Das, Aashis Dutta, Ananya Chetia, Pliza Kalita, Sushil Nagar   +7 more
wiley   +1 more source

Gout therapy updated. [PDF]

Ther Adv Musculoskelet Dis
McCarty KL, Gaffo AL, Diaz-Torne C.
europepmc   +1 more source